Metraipolis › archive › dc_ad5afbee9088

Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies — Europe PMC PMID:42069769

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42069769
DOI
10.1186/s40780-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-16T05:08:56.622Z
SHA-256 of the archived text
7d8083d703bbffa4ae6fffaa9bd5b792e4daf42453890c584b9e2c4b998ada14
Stable URL of this page
https://metraipolis.com/documento/dc_ad5afbee9088

How to cite

Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies — Europe PMC PMID:42069769 — Europe PMC (en), https://europepmc.org/article/MED/42069769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad5afbee9088 (Metraipolis archive dc_ad5afbee9088, sha256 7d8083d703bbffa4ae6fffaa9bd5b792e4daf42453890c584b9e2c4b998ada14)
BibTeX
@misc{dcad5afbee9088,
  title = {Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies — Europe PMC PMID:42069769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42069769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad5afbee9088; sha256 7d8083d703bbffa4ae6fffaa9bd5b792e4daf42453890c584b9e2c4b998ada14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42069769. Agents can read the archived copy with the MCP tool read_document.